[1]CurrentPatentAssignee:PFIZERINC-US2004/6245,2004,A1Locationinpatent:Page25
[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2006/14580,2006,A1Locationinpatent:Page/Pagecolumn52
[1]Patent:WO2017/147102,2017,A1.Locationinpatent:Paragraph00250-00251
27899-21-4 | 2,4-Diethylglutaric acid | AA003FP8 | MFCD04117827
2809-69-0 | 2,4-HEXADIYNE | AA003FSO | MFCD00041617
3600-86-0 | 2,5-Dimethoxyphenethylamine | AA003FW9 | MFCD00060614
13600-42-5 | 3-Cyano-2,6-dichloro-4-(trifluoromethyl)pyridine | AA003G01 | MFCD00084977
961-27-3 | 2,7-DIACETYLFLUORENE | AA003G3S | MFCD00045332
932-16-1 | 2-Acetyl-1-methylpyrrole | AA003G80 | MFCD00003089
21331-43-1 | 4-(2-Naphthyl)-1,3-thiazol-2-amine hydrobromide | AA003GB9 | MFCD00046452
578007-67-7 | 2-Amino-5-iodopyridine-3-carboxaldehyde | AA003GED | MFCD05663523
42712-64-1 | 2-Amino-4-hydroxyquinoline hydrate | AA003GHC | MFCD11656651
64695-82-5 | 2-Bromo-4,5-difluorobenzonitrile | AA003GKT | MFCD00061016
2171803-53-3
910650-82-7
307543-57-3
955634-28-3